10篇
您的检索式：作者名="Sutherland BG"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatocellular Transplantation for treatment of D-galactosamine-induced acute liver failure in rats显示文摘 | Sommer BG sutherland DER Matas AJ | 1979 | Trans Proc1979，11，： | 1 |
| 2 | An engineered human antibody to TNF (CDP571) for active Crohn's disease:a randomized double-blind placebo-controlled trial显示文摘 | Sandborn WJ Feagan BG Hanauer SB Present DH Sutherland LR Kamm MA Wolf DC Baker JP Hawkey C Archambault A Bernstein CN Novak C Heath PK Targan SR CDP571 Crohn's Disease Study Group | 2001 | Gastroenterology2001，120，6： | 1 |
| 3 | A randomized,double-blind,placebo-contralled,multi-center trial of the engineered human antibody to TNF(CDP571) for steroid sparing znd maintenance of remission in patients with steroid-dependent Crohn'sdisease显示文摘 | Feagan BG Sandborn WJ Baker J Comineli F Sutherland LR Elson C Salzberg B Archambault A Bernstein C Lichtenstein G Heath PK Hanauer SB | 2000 | Gastroenterology2000，118，： | 1 |
| 4 | Naringe-nin prevents dyslipidemia, apoB overproduction and hyper-sulin resistance显示文摘 | Mulvihill EE Allister EM Sutherland BG | 2009 | Diabetes2009，58，： | 1 |
| 5 | Naringenin prevents dyslipidemia,apolipoprotein B overproduction,and hyperinsulinemia in LDL receptor-null mice with diet-induce dinsulin resistance显示文摘 | Mulvihill EE Allister EM Sutherland BG | 2009 | Diabetes2009，58，10： | 1 |
| 6 | Primer samplifying a range of Prunus S-alleles 显示文摘 | Sutherland BG Robbins T P Tobutt K R | 2004 | Plant Breed2004，123，： | 1 |
| 7 | Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr(-)/(-) mice显示文摘 | Assini JM Mulvihill EE Sutherland BG | 2013 | J Lipid Res2013，54，3： | 1 |
| 8 | Primers amplifying a range of Prunus S -alleles显示文摘 | Sutherland BG Robbins T P Tobutt K R | 2004 | Plant Breeding2004，123，： | 1 |
| 9 | Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor - null mice with diet-induced insulin resistance显示文摘 | Mulvihill EE Allister EM Sutherland BG | 2009 | Diabetes2009，58，10： | 1 |
| 10 | The molecu- lar mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin 显示文摘 | Telford DE Sutherland BG Edwards JY | 2007 | J Lipid Res2007，48，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员